SWOG S0709: Randomized phase II trial of erlotinib versus erlotinib plus carboplatin/paclitaxel in patients with advanced non-small cell lung cancer and impaired performance status as selected by a serum proteomics assay

Primo N Lara, James Moon, Paul J. Hesketh, Mary W. Redman, Stephen K. Williamson, Wallace L. Akerley, Fred R. Hirsch, Philip Mack, David R Gandara

Research output: Contribution to journalReview articlepeer-review

9 Scopus citations

Fingerprint

Dive into the research topics of 'SWOG S0709: Randomized phase II trial of erlotinib versus erlotinib plus carboplatin/paclitaxel in patients with advanced non-small cell lung cancer and impaired performance status as selected by a serum proteomics assay'. Together they form a unique fingerprint.

Medicine & Life Sciences